BEONE MEDICINES LTD. (BEIGF) Free cash flow 2016–2025
BEONE MEDICINES LTD. (BEIGF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$941.7MFY2025 · since FY2016: -$113.0M → $941.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $941.7M | +248.7% |
| FY2024 | -$633.3M | +63.2% |
| FY2023 | -$1.7B | +5.6% |
| FY2022 | -$1.8B | -16.7% |
| FY2021 | -$1.6B | -11.5% |
| FY2020 | -$1.4B | -66.8% |
| FY2019 | -$839.9M | -35.9% |
| FY2018 | -$618.0M | -1738.1% |
| FY2017 | -$33.6M | +70.2% |
| FY2016 | -$113.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BEIGF financial trends
BEIGF RevenueBEIGF Net incomeBEIGF Net marginBEIGF Gross profitBEIGF Gross marginBEIGF Operating incomeBEIGF Operating marginBEIGF Operating cash flowBEIGF Capital expendituresBEIGF Return on equityBEIGF Stock buybacksBEIGF Dividends paidBEIGF Total assetsBEIGF Total liabilitiesBEIGF Shareholders’ equityBEIGF overview →